To support this, we depleted USP8 in two well-established doxorubicin-resistant HCC lines: HuH6-r and HepG2-r [16, 19] and confirmed the efficacy of siRNA knockdown (Figure 2D and Supplementary Figure 1B). This evidence concerns the gene USP8 and hepatocellular carcinoma.